7.4145

0.34% -0.0155

Precision Biosciences Inc (DTIL)

Overview News Price History Option Chain Financials Discussions Forecast

Precision Biosciences Inc stock is traded at $7.4145, with a volume of 140.24K. It is down -0.34% in the last 24 hours and down -5.91% over the past month. Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Previous Close:

$7.43

Open:

$7.45

24h Volume:

140.24K

Relative Volume:

0.33

Market Cap:

$204.80M

Revenue:

$45.07M

Net Income/Loss:

$-44.49M

P/E Ratio:

-1.9953

EPS:

-3.716

Net Cash Flow:

$-54.23M

1W Performance:

-0.74%

1M Performance:

-5.91%

6M Performance:

+85.59%

1Y Performance:

+57.22%

1-Day Range:

$7.37

$7.54

1-Week Range:

$7.18

$7.75

52-Week Range:

$3.53

$9.62

Precision Biosciences Inc Stock (DTIL) Company Profile

Name

Precision Biosciences Inc

Sector

Healthcare (1089)

Industry

Biotechnology (604)

Phone

919-314-5512

Address

302 EAST PETTIGREW STREET, DURHAM, NC

Employee

Twitter

@PrecisionBioSci

Next Earnings Date

2026-08-06

Latest SEC Filings

DTIL's Discussions on Twitter

Compare DTIL vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DTIL Precision Biosciences Inc	7.42	205.08M	45.07M	-44.49M	-54.23M	-3.716
VRTX Vertex Pharmaceuticals Inc	515.44	128.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	806.90	82.72B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	992.82	53.26B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	215.68	43.66B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	362.27	39.31B	5.76B	514.49M	1.10B	4.4813

Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-10-25	Upgrade	BMO Capital Markets	Market Perform → Outperform
Apr-30-24	Initiated	Guggenheim	Buy
Jun-17-22	Initiated	BMO Capital Markets	Outperform
Jun-09-22	Downgrade	William Blair	Outperform → Mkt Perform
Jul-27-20	Resumed	BTIG Research	Buy
Apr-03-20	Downgrade	Goldman	Buy → Neutral
Mar-05-20	Initiated	Stifel	Buy
Feb-25-20	Initiated	William Blair	Outperform
Aug-09-19	Initiated	BTIG Research	Buy
Jul-16-19	Initiated	H.C. Wainwright	Buy
Apr-22-19	Initiated	Barclays	Overweight
Apr-22-19	Initiated	Goldman	Buy
Apr-22-19	Initiated	JP Morgan	Overweight
Apr-22-19	Initiated	Jefferies	Buy

View All

Precision Biosciences Inc Stock (DTIL) Latest News

Aug 16, 2026

Precision BioSciences Inc Stock Intrinsic Values | HAM:PBS0 - GuruFocus

Aug 16, 2026

Precision BioSciences Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Aug 16, 2026

Precision BioSciences Inc (HAM:PBS0) Competitors 2026 - GuruFocus

Aug 16, 2026

Precision BioSciences Inc Stock Warning Signs | HAM:PBS0 - GuruFocus

Aug 16, 2026

Who's Buying or Selling Precision BioSciences Inc (HAM:PBS0) Stock Today? - GuruFocus

Aug 16, 2026

Precision BioSciences Inc (HAM:PBS0) Stock Price & 30 Year Financial Data - GuruFocus

Aug 16, 2026

Precision BioSciences Inc (HAM:PBS0) Stock Earnings Transcripts - GuruFocus

Aug 16, 2026

Precision BioSciences Inc (HAM:PBS0) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus

Aug 16, 2026

HAM:PBS0 Dividend: Does Precision BioSciences Inc Pay a Dividend? - GuruFocus

Aug 16, 2026

Precision BioSciences Inc (HAM:PBS0) Stock Price, Trades & News - GuruFocus

Aug 16, 2026

Precision BioSciences Inc (HAM:PBS0) Stock News, Headlines & Updates - GuruFocus

Aug 16, 2026

Aug 11, 2026